Reduced-intensity allogeneic hematopoietic stem cell transplantation combined with imatinib has comparable event-free survival and overall survival to long-term imatinib treatment in young patients with chronic myeloid leukemia.
about
Reduced-intensity allogeneic hematopoietic stem cell transplantation combined with imatinib has comparable event-free survival and overall survival to long-term imatinib treatment in young patients with chronic myeloid leukemia.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Reduced-intensity allogeneic h ...... with chronic myeloid leukemia.
@en
Reduced-intensity allogeneic h ...... with chronic myeloid leukemia.
@nl
type
label
Reduced-intensity allogeneic h ...... with chronic myeloid leukemia.
@en
Reduced-intensity allogeneic h ...... with chronic myeloid leukemia.
@nl
prefLabel
Reduced-intensity allogeneic h ...... with chronic myeloid leukemia.
@en
Reduced-intensity allogeneic h ...... with chronic myeloid leukemia.
@nl
P2093
P2860
P1433
P1476
Reduced-intensity allogeneic h ...... with chronic myeloid leukemia
@en
P2093
Jiasheng Wang
Weiyan Zheng
Yanmin Zhao
P2860
P304
P356
10.1007/S00277-017-3021-Y
P50
P577
2017-06-17T00:00:00Z